Rhaponiticin
CAS No. 155-58-8
Rhaponiticin ( —— )
产品货号. M18081 CAS No. 155-58-8
大黄苷(Rhaponiticin)能够减轻KK/Ay糖尿病小鼠的肝脏脂肪变性,改善血糖和血脂,表明大黄苷具有明显的抗糖尿病作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥246 | 有现货 |
|
| 10MG | ¥353 | 有现货 |
|
| 25MG | ¥693 | 有现货 |
|
| 50MG | ¥1014 | 有现货 |
|
| 100MG | ¥1458 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥377 | 有现货 |
|
生物学信息
-
产品名称Rhaponiticin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述大黄苷(Rhaponiticin)能够减轻KK/Ay糖尿病小鼠的肝脏脂肪变性,改善血糖和血脂,表明大黄苷具有明显的抗糖尿病作用。
-
产品描述Rhaponticin(Rhaponiticin) can alleviate liver steatosis and improve blood glucose and lipid profiles in KK/Ay diabetic mice, indicates that rhaponticin has a noticeable antidiabetic effect and could be potentially used as a new agent to treat type 2 diabetes mellitus and its complications.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number155-58-8
-
分子量420.41
-
分子式C21H24O9
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 250 mg/mL (594.66 mM)
-
SMILESCOC1=C(C=C(C=C1)C=CC2=CC(=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
ATI-2341 TFA
ATI-2341 is an effective functionally selective allosteric agonist for the c-x-c chemokine receptor type 4 (CXCR4), which ACTS as a biased ligand in favor of G G G G G 1 activation instead of G G G G G 13.ATI-2341 activates the inhibitory heterotrimer G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization.ATI-2341 is an effective mobilization agent for myeloid polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs).
-
Amifostine trihydrat...
氨磷汀是第一种批准的放射防护化合物,用于降低顺铂治疗引起的肾脏问题的风险。
-
Calmagite
钙镁石是一种指示剂,可用于检测各种样品中的镁和钙。
021-51111890
购物车()
sales@molnova.cn

